Clinical Trial Update: Dolastatin 10 in Treating Patients With Advanced Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of Dolastatin 10 for advanced kidney cancer has completed. The update does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Dolastatin 10 (dolastatin-10)

Snippet

Sponsor: Mayo Clinic | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED